AMRX · US market

Amneal Pharmaceuticals, Inc.

Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.

Market cap US$6.41bnFinancials dated 30 June 2026Price dated 1 October 2026

Core valuation

Trailing P/E40.73×

Latest-quarter run-rate P/E27.79×

Trailing P/S2.06×

Latest-quarter run-rate P/S2.01×

Calculation inputs

Trailing earnings: US$157.36m
Latest-quarter run-rate earnings: US$230.65m
Latest fiscal-year earnings: US$72.06m
Trailing revenue: US$3.12bn
Latest-quarter run-rate revenue: US$3.18bn
Latest fiscal-year revenue: US$3.02bn

Featured ETF and mutual-fund exposure

These public funds report this company in their latest disclosed holdings.

PJP · Invesco Pharmaceuticals ETF2.58% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
XPH · State Street SPDR S&P Pharmaceuticals ETF1.65% weight · Holdings dated 21 August 2026
NSVBX · Columbia Small Cap Value and Inflection Fund Class S1.49% weight · Holdings dated 31 May 2026
PCVAX · Virtus NFJ Small-Cap Value Fund Class A1.35% weight · Holdings dated 30 June 2026
PSCH · Invesco S&P SmallCap Health Care ETF1.19% weight · Holdings dated 31 May 2026
PYSVX · Putnam Small Cap Value Fund Class Y1.06% weight · Holdings dated 31 May 2026
PTH · Invesco Dorsey Wright Healthcare Momentum ETF1.00% weight · Holdings dated 19 August 2026
ASQAX · American Century Small Company Fund A Class0.85% weight · Holdings dated 30 June 2026
AFDZX · Applied Finance Explorer Fund Institutional Shares0.79% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
FTXH · First Trust Nasdaq Pharmaceuticals ETF0.69% weight · Holdings dated 30 June 2026

Sources and limitations

Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.

Open financial source

Financials as of 30 June 2026. Informational research, not investment advice.